
Maven Bio is a 10-person seed-stage team in Boston building the market intelligence layer for life sciences AI. Three of the top 10 pharma companies are onboarded, and we have 20+ enterprise accounts across pharma, consulting, and investing. Customers report a 40% reduction in low-level analytical work. We are growing fast and heading for a Series A. Our buyers are senior BD, CI, Strategy, and Investing leaders.
Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →